Elevation Oncology Inc (ELEV)
0.6139
-0.08
(-10.93%)
USD |
NASDAQ |
Nov 13, 16:00
0.6023
-0.01
(-1.89%)
After-Hours: 20:00
Elevation Oncology Price to Book Value: 0.5233 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2024 | 0.5875 |
| November 11, 2024 | 0.5711 |
| November 08, 2024 | 0.554 |
| November 07, 2024 | 0.4919 |
| November 06, 2024 | 0.4688 |
| November 05, 2024 | 0.4774 |
| November 04, 2024 | 0.4455 |
| November 01, 2024 | 0.4569 |
| October 31, 2024 | 0.4895 |
| October 30, 2024 | 0.5114 |
| October 29, 2024 | 0.5055 |
| October 28, 2024 | 0.5078 |
| October 25, 2024 | 0.4961 |
| October 24, 2024 | 0.532 |
| October 23, 2024 | 0.512 |
| October 22, 2024 | 0.5572 |
| October 21, 2024 | 0.4988 |
| October 18, 2024 | 0.4908 |
| October 17, 2024 | 0.4699 |
| October 16, 2024 | 0.4707 |
| October 15, 2024 | 0.4424 |
| October 14, 2024 | 0.4396 |
| October 11, 2024 | 0.4369 |
| October 10, 2024 | 0.4269 |
| October 09, 2024 | 0.4407 |
| Date | Value |
|---|---|
| October 08, 2024 | 0.4453 |
| October 07, 2024 | 0.4623 |
| October 04, 2024 | 0.4589 |
| October 03, 2024 | 0.4439 |
| October 02, 2024 | 0.4899 |
| October 01, 2024 | 0.4777 |
| September 30, 2024 | 0.5114 |
| September 27, 2024 | 0.431 |
| September 26, 2024 | 0.4203 |
| September 25, 2024 | 0.4222 |
| September 24, 2024 | 0.4341 |
| September 23, 2024 | 0.4202 |
| September 20, 2024 | 0.428 |
| September 19, 2024 | 0.4381 |
| September 18, 2024 | 0.434 |
| September 17, 2024 | 0.4408 |
| September 16, 2024 | 0.4456 |
| September 13, 2024 | 0.4447 |
| September 12, 2024 | 0.4456 |
| September 11, 2024 | 0.4408 |
| September 10, 2024 | 0.4454 |
| September 09, 2024 | 0.4602 |
| September 06, 2024 | 0.4565 |
| September 05, 2024 | 0.4748 |
| September 04, 2024 | 0.489 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2293
Minimum
Sep 22 2022
4.554
Maximum
Mar 28 2024
1.085
Average
0.5981
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.574 |
| AIM ImmunoTech Inc | 2.423 |
| IGC Pharma Inc | 3.465 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 3.165 |
Price to Book Value Related Metrics
| Price | 0.6139 |
| Earnings Yield | -135.2% |
| Market Cap | 36.29M |